Xiaoying Hou

Key Laboratory Of Neuropsychiatric Diseases
Nanjing, 211198, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

GPR139-mediated cholinergic circuit from the medial septum to the ventral hippocampal CA3 modulates cognitive impairment in Alzheimer's disease.

GPR139-mediated cholinergic circuit from the medial septum to the ventral hippocampal CA3 modulates cognitive impairment in Alzheimer's disease.

Journal: Neuropharmacology

Published: October 09, 2025

Up-regulation of GPR139 in the medial septum ameliorates cognitive impairment in two mouse models of Alzheimer's disease.

Up-regulation of GPR139 in the medial septum ameliorates cognitive impairment in two mouse models of Alzheimer's disease.

Journal: International immunopharmacology

Published: January 11, 2024

Akkermansia Muciniphila Potentiates the Antitumor Efficacy of FOLFOX in Colon Cancer.

Akkermansia Muciniphila Potentiates the Antitumor Efficacy of FOLFOX in Colon Cancer.

Journal: Frontiers in pharmacology

Published: June 15, 2021

Oleic Acid and Insulin as Key Characteristics of T2D Promote Colorectal Cancer Deterioration in Xenograft Mice Revealed by Functional Metabolomics.

Oleic Acid and Insulin as Key Characteristics of T2D Promote Colorectal Cancer Deterioration in Xenograft Mice Revealed by Functional Metabolomics.

Journal: Frontiers in oncology

Published: March 24, 2021

Novel Quinoline Compound Derivatives of NSC23925 as Potent Reversal Agents Against P-Glycoprotein-Mediated Multidrug Resistance.

Novel Quinoline Compound Derivatives of NSC23925 as Potent Reversal Agents Against P-Glycoprotein-Mediated Multidrug Resistance.

Journal: Frontiers in chemistry

Published: July 21, 2019

Untargeted Metabolomics Study of the In Vitro Anti-Hepatoma Effect of Saikosaponin d in Combination with NRP-1 Knockdown.

Untargeted Metabolomics Study of the In Vitro Anti-Hepatoma Effect of Saikosaponin d in Combination with NRP-1 Knockdown.

Journal: Molecules (Basel, Switzerland)

Published: March 01, 2019

Two novel camptothecin derivatives inhibit colorectal cancer proliferation via induction of cell cycle arrest and apoptosis in vitro and in vivo.

Two novel camptothecin derivatives inhibit colorectal cancer proliferation via induction of cell cycle arrest and apoptosis in vitro and in vivo.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: April 04, 2018

DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.

DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: March 12, 2018

Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway.

Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway.

Journal: Frontiers in pharmacology

Published: October 09, 2017

PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC.

PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC.

Journal: Cell death & disease

Published: May 15, 2017

DT-13 synergistically potentiates the sensitivity of gastric cancer cells to topotecan via cell cycle arrest in vitro and in vivo.

DT-13 synergistically potentiates the sensitivity of gastric cancer cells to topotecan via cell cycle arrest in vitro and in vivo.

Journal: European journal of pharmacology

Published: May 04, 2017

PLOD2 in cancer research.

PLOD2 in cancer research.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 08, 2017

Showing 1-12 of 13

Last Updated: 09/26/2026